CD9 and colorectal cancer: In fact, CD147, which is considered a biomarker for early-stage colorectal cancer, and CD9 double-positive EVs were also detected in samples with early-stage colorectal cancer that had invaded the submucosal layer by the ExoScreen assay [101].